|
Variables
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
HR (95%CI)
|
P
|
HR (95%CI)
|
P
|
|---|
|
I-III stage
|
|
Age (≥55 vs. < 55)
|
0.832(0.447-1.548)
|
0.562
|
0.808(0.416-1.572)
|
0.53
|
|
Sex (Male vs. Female)
|
0.842(0.453-1.566)
|
0.587
|
1.166(0.596-2.284)
|
0.653
|
|
TNM stage (I-III)
|
2.157(1.359-3.423)
|
0.001**
|
2.208(1.368-3.562)
|
0.001**
|
|
MACC1 expression(high vs. low and negative)
|
2.144(1.160-3.963)
|
0.015*
|
2.004(1.054-3.809)
|
0.034*
|
|
MACC1-AS1 expression (high vs. low and negative)
|
2.194(1.218-3.952)
|
0.009**
|
1.913(1.041-3.516)
|
0.037*
|
|
IV stage
|
|
Age (≥55 vs. < 55)
|
1.121(0.493-2.546)
|
0.786
|
1.722(0.675-4.395)
|
0.255
|
|
Sex (Male vs. Female)
|
0.971(0.423-2.226)
|
0.944
|
2.162(0.726-6.445)
|
0.166
|
|
MACC1 expression((high vs. low and negative)
|
2.751(1.155-6.554)
|
0.022*
|
2.889(1.122-7.443)
|
0.028*
|
|
MACC1-AS1 expression (high vs. low and negative)
|
2.572(1.162-5.692)
|
0.020*
|
2.509(1.025-6.143)
|
0.044*
|
- Abbreviations: HR hazard ratio, CI confidence interval, *P<0.05, **P<0.01
